Revive Therapeutics Ltd. (RVV)

Revive Therapeutics Logo White

Revive Therapeutics

CSE: RVV | OTC: RVVTF 

Revive Therapeutics is focused on the R&D and sale of cannabinoid-based products, recently expanding into the psychedelics industry more broadly.

Revive Therapeutics
$0.5000
-1.96%
$0.0100

Latest News

Revive Collaborates With University of Health Sciences Antigua To Pioneer Clinical Research of Psychedelics

June 17, 2021

Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip

May 17, 2021

Revive Therapeutics Files for FDA Orphan Drug Designation for Psilocybin in Traumatic Brain Injury

April 27, 2021

Revive Therapeutics Announces Successful Research Results for Oral Thin Film Psilocybin and Filing of U.S. Provisional Patent Application

April 22, 2021

Revive Therapeutics Announces Successful Research Results for Psilocybin to Treat Traumatic Brain Injury and Filing of International Patent Application

March 19, 2021

Revive Therapeutics Acquires Unique Psilocybin Assets

February 17, 2021

Join our Newsletter

Get the latest Company updates delivered to straight to your inbox.